1
Jonathan W Uhr, Ellen S Vitetta, Richard H Scheuermann: Epitope-specific monoclonal antibodies and immunotoxins and uses thereof. Board of Regents The University of Texas, Arnold White & Durkee, November 11, 1997: US05686072 (133 worldwide citation)

The anti-tumor activity of a mixture of anti-CD22 and anti-CD19 immunotoxins is shown to be significantly enhanced in SCID/Daudi mice with disseminated human Daudi lymphoma. Unexpectedly identical enhancement was observed employing a combination of the anti-CD22 immunotoxin with unconjugated anti-CD ...


2
Jonathan W Uhr, Ellen S Vitetta, Louis J Picker, Richard H Scheuermann: Method for identifying tumor cells in cell cycle arrest. Board of Regents The University of Texas System, Arnold White & Durkee, March 18, 1997: US05612185 (8 worldwide citation)

Disclosed are methods for the identification and characterization of tumor cell types present within malignant populations, and novel methods of cancer treatment. Tumor cells in cell cycle arrest have been identified, purified and characterized according to their size, altered morphology, surface ph ...


3
Brian M Fendly, Gail Dianne Phillips, Richard H Scheuermann, Jonathan W Uhr: Anti-ErbB2 antibodies. Board of Regents The University of Texas System, Genentech, Merchant & Gould PC, May 15, 2008: US20080112957-A1

Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.


4
Brian M Fendly, Gail Dianne Phillips, Richard H Scheuermann, Jonathan W Uhr: ANTI-ErbB2 ANTIBODIES. Arnold & Porter, February 10, 2011: US20110033460-A1

Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.